INHIBITEX, INC. Common Stock (par value $0.001 per share) At Market Issuance Sales AgreementAt Market Issuance Sales Agreement • November 24th, 2010 • Inhibitex, Inc. • Biological products, (no disgnostic substances) • New York
Contract Type FiledNovember 24th, 2010 Company Industry JurisdictionInhibitex, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with McNicoll, Lewis & Vlak LLC (“MLV”), as follows: